Subjects: BREAST cancer research; TRASTUZUMAB; CLINICAL trialsUNITED StatesIMMUNOGEN Inc. 011991874 IMMUNOGEN Inc. IMMUNOGEN Inc. 011991874 011991874 IMMUNOGEN Inc. 011991874 IMGN; GENENTECH Inc. GENENTECH Inc. GENENTECH Inc. DNA...
Record details
Subjects: BREAST cancerUNITED StatesAVID Bioservices Inc. ; CELSION Corp. ; WAFERGEN Biosystems Inc. WAFERGEN Biosystems Inc. WAFERGEN Biosystems Inc. WGBS
Subjects: *CONTRACTS; BREAST cancer treatment; CANCER patientsUNITED StatesIMCLONE Systems Inc. 131345761 IMCLONE Systems Inc. IMCLONE Systems Inc. 131345761 131345761 IMCLONE Systems Inc. 131345761 IMCL; GENENTECH Inc. GENENTECH Inc. GENENTECH Inc. DNA; ABRAXIS BioScience Inc.
Subjects: BREAST cancer research; CANCER treatmentUNITED StatesAPTHERA Inc. ; CASI Pharmaceuticals Inc. 796176915 CASI Pharmaceuticals Inc. CASI Pharmaceuticals Inc. 796176915 796176915 CASI Pharmaceuticals Inc. 796176915 ENMD; IMCLONE Systems Inc. 131345761 IMCLONE Systems Inc. IMCLONE Systems Inc. 131345761 131345761 IMCLONE Systems Inc. 131345761 IMCL
Subjects: DRUG development; BREAST cancer; CANCER treatmentUNITED StatesYM BioSciences Inc. ; ABRAXIS BioScience Inc. ; CASI Pharmaceuticals Inc. 796176915 CASI Pharmaceuticals Inc. CASI Pharmaceuticals Inc. 796176915 796176915 CASI Pharmaceuticals Inc. 796176915 ENMD
Subjects: BREAST cancer; DRUG marketingUNITED StatesBAYER HealthCare Pharmaceuticals Inc. ; ASTRAZENECA PLC ASTRAZENECA PLC ASTRAZENECA PLC AZN; GLAXOSMITHKLINE
Subjects: *PHARMACEUTICAL industry; CANCER treatment; BREAST cancerUNITED StatesPFIZER Inc. 001326495 PFIZER Inc. PFIZER Inc. 001326495 001326495 PFIZER Inc. 001326495 PFE; GENENTECH Inc. GENENTECH Inc. GENENTECH Inc. DNA
Subjects: BREAST cancer; CANCER treatment; CLINICAL trialsUNITED StatesGLAXOSMITHKLINE ; UNITED States. Food & Drug Administration ; CASI Pharmaceuticals Inc. 796176915 CASI Pharmaceuticals Inc. CASI Pharmaceuticals Inc. 796176915 796176915 CASI Pharmaceuticals Inc. 796176915 ENMD
Subjects: BREAST cancerUNITED StatesUNITED States. Food & Drug Administration ; NOVARTIS AG 001221845 NOVARTIS AG NOVARTIS AG 001221845 001221845 NOVARTIS AG 001221845 NVS; INTROGEN Therapeutics Inc. INTROGEN Therapeutics Inc. INTROGEN Therapeutics Inc. 878974153
Subjects: ANTINEOPLASTIC agents; BREAST cancer treatment; TAMOXIFENUNITED StatesASTRAZENECA PLC ASTRAZENECA PLC ASTRAZENECA PLC AZN